Pharmaceutical composition for treating inflammation and pain
AssigneeOlatec Therapeutics LLC
InventorsJoseph ST. LAURENT, Gerald S. JONES, David M. BRESSE
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
Claims13
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and 5-methanesulfonylpentanenitrile or 7-methanesulfonylheptanenitrile, or a pharmaceutically acceptable solvate thereof.
Dependencies are inferred from the claim text.